Reports EPS of $1.71, Economic EPS of $3.16Completed investment in Garda Capital PartnersCompleted BlueMountain transaction and received approximately $90 million […]
NEWTON, Mass., Oct. 28, 2019 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced that it […]